RSS

Issue 17.4

In the latest instalment of the lab diary, R&D software provider, IDBS, examines why pharma companies should be implementing cloud software. Read more

Opinion

The Queen’s Awards for Enterprise are prestigious awards given to companies for outstanding achievements in four categories. Here we briefly run through some of this year’s winners in the fields of innovation and international trade. Read more

News

Mark Kelly, 3M Ireland, reflects on some of the challenges facing the biotechnology industry, and explains how the science-based technology company is rising to them. Read more

Opinion

Lyophilisation is crucial in the creation of pharmaceutical ingredients with an extended shelf life, however, current methods can still be costly and time consuming. Hosokawa Micron reveals its new method of contained active freeze drying Read more

Opinion

We talk to Dr Nik Marchetti, product manager of Lhasa Limited, a not-for-profit organisation and educational charity, about products, developments and innovations driving the company forwards. Read more

Opinion

Doug Millington-Smith, principal applications specialist at powder characterisation company Freeman Technology, considers the value of multivariate powder characterisation as a solution to the demand for comprehensive data. Read more

Opinion

Richard Lewis of Biopharma Group looks at the rise of low maintenance, automated aseptic processing lines. Read more

Opinion

Chris Wilkinson, head of sales for Healthcare for Siemens Financial Services in the UK, looks at the value of new-generation digitalised technology within the pharmaceutical industry. Read more

Opinion

Narasimharaju SN, senior manager — regulatory affairs and Mac Kella, senior regulatory affairs executive at ELC Group assess whether biosimilars are really interchangeable in the EU. Read more

, Opinion 1 Comments

The UK’s separation from the EU could have implications for regulatory harmonisation, and increase administrative workloads at a time when responsible teams are already overstretched and experienced talent is hard to find. Read more

Opinion

How do managers in the pharmaceutical industry ensure that their plant performs reliably and safely? Michael Dixey and Pete Hibbs of GGR Associates explain some of the reasons for poor performance and suggest how these problems may be overcome. Read more

, Opinion

After recent events, it seems that more than ever protective measures are made to ensure pharma is a safe space for companies and patients. Read more

Opinion

In light of the upcoming snap general election, we pick through the three big parties’ policies and various industry analyses of these policies. Read more

News

In this article, Eric Tjoa, CEO and founder at Tjoapack, outlines a brief history of track and trace and explores the future for serialisation, including the opportunities that technology can bring to the sector and most importantly, patient safety Read more

Opinion

Erik Haeffler, vice president of manufacturing services, Recipharm, examines the challenges and opportunities for a CDMO in the landscape of serialisation that contract partners must overcome. Read more

Opinion